Immunoassay of carcinogen-modified DNA.
D015073:2-Acetylaminofluorene / Q000276:immunology; D000348:Aflatoxins / Q000276:immunology; D000478:Alkylation; D000911:Antibodies, Monoclonal; D000915:Antibody Affinity; D000918:Antibody Specificity; D001483:Base Sequence; D001564:Benzo(a)pyrene / Q000276:immunology; D002273:Carcinogens / Q000276:immunology*; D002945:Cisplatin / Q000276:immunology; D004247:DNA / Q000276:immunology* / Q000528:radiation effects; D006241:Haptens; D007115:Immunization Schedule; D007158:Immunologic Techniques; D009690:Nucleic Acid Conformation; D009705:Nucleosides / Q000276:immunology; D009711:Nucleotides / Q000276:immunology; D011119:Polynucleotides / Q000276:immunology; D012313:RNA / Q000276:immunology; D011839:Radiation, Ionizing; D014466:Ultraviolet Rays
D000348:Aflatoxins; D000911:Antibodies, Monoclonal; D002273:Carcinogens; D006241:Haptens; D009705:Nucleosides; D009711:Nucleotides; D011119:Polynucleotides; D001564:Benzo(a)pyrene; D012313:RNA; D004247:DNA; D015073:2-Acetylaminofluorene; D002945:Cisplatin